Back
Carlisle Companies 10K Form
Buy
52
CSL
Carlisle Companies
Last Price:
447.34
Seasonality Move:
8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-27 | 10Q | CSL/Carlisle Companies Quarterly |
2023-07-27 | 10Q | CSL/Carlisle Companies Quarterly |
2023-04-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-10-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-07-28 | 10Q | CSL/Carlisle Companies Quarterly |
2022-04-29 | 10Q | CSL/Carlisle Companies Quarterly |
Receive CSL News And Ratings
See the #1 stock for the next 7 days that we like better than CSL
CSL Financial Statistics
Sales & Book Value
Annual Sales: | $4.59B |
---|---|
Cash Flow: | $293.5M |
Price / Cash Flow: | 23.03 |
Annual Sales: | $60.86 |
Price / Book: | 7.39 |
Profitability
EPS (TTM): | 28.26000 |
---|---|
Net Income (TTM): | $1.35B |
Gross Margin: | $1.63B |
Return on Equity: | 47.1% |
Return on Assets: | 20.35% |
Carlisle Companies Earnings Forecast
Key Carlisle Companies Financial Ratios
- The Gross Profit Margin over the past 40 years for CSL is 35.63%.
- The Selling, General & Administrative Expenses for CSL have been equal to 13.63% of Gross Profit Margin.
- The Research & Development expenses have been 0.63% of Revenue.
- The Interest Expense is 9.85% of Operating Income.
- The Net Earning history of CSL is 16.73% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
Carlisle Companies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Building Products |
Sector: | Industrials |
Current Symbol: | CSL |
CUSIP: | 142339 |
Website: | carlisle.com |
Debt
Debt-to-Equity Ratio: | 0.83 |
---|---|
Current Ratio: | 2.73 |
Quick Ratio: | 2.18 |
Price-to-Earnings
Trailing P/E Ratio: | 29.68 |
---|---|
Forward P/E Ratio: | 19.73 |
CSL Technical Analysis vs Fundamental Analysis
Buy
52
Carlisle Companies (CSL)
is a Buy
Is Carlisle Companies a Buy or a Sell?
-
Carlisle Companies stock is rated a Buy
The current Carlisle Companies [CSL] share price is $450.58. The Score for CSL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.